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a- and b-neurexins (NRXNs) are transmembrane cell
adhesion proteins that localize to presynaptic
membranes in neurons and interact with the postsyn-
aptic neuroligins (NLGNs). Their gene mutations are
associated with the autism spectrum disorders. The
extracellular region of a-NRXNs, containing nine
independently folded domains, has structural
complexity and unique functional characteristics,
distinguishing it from the smaller b-NRXNs. We have
solved theX-raycrystal structureof sevencontiguous
domains of the a-NRXN-1 extracellular region at 3.0 A˚
resolution. The structure reveals an arrangement
where the N-terminal five domains adopt amore rigid
linear conformation and the two C-terminal domains
form a separate arm connected by a flexible hinge.
In an extended conformation the molecule is suitably
configured to accommodate a bound NLGN mole-
cule, as supported by structural comparison and
surface plasmon resonance. These studies provide
the structural basis for a multifunctional synaptic
adhesion complex mediated by a-NRXN-1.
INTRODUCTION
Specialized synaptic adhesion proteins play an important role
in synapse specification, development, and maintenance. Genetic
evidence implicates several synaptic adhesion proteins in the
onset of neurodevelopmental disorders, such as the autism
spectrum disorders (ASD) (Abrahams and Geschwind, 2008). The
NRXN-1 gene has been identified as one candidate for sus-
ceptibility to ASD in multiple genetic linkage studies, ranging from
whole-genome scans to single-nucleotide polymorphism (SNP)
screens (Glessner et al., 2009; Kim et al., 2008; Sebat et al., 2007;
Szatmari et al., 2007; Yan et al., 2008). The neurexins (NRXNs)
constitute a family of presynaptic transmembrane proteins,
which are developmentally and spatially expressed at neuronal
GABAergic and glutamatergic synapses (Ullrich et al., 1995).
In vertebrates, there are three NRXN genes (NRXN 1-3), each
encoding either the longer a-NRXN or the shorter b-NRXN viaStructure 19alternative promoter regions. For each gene, the a- and
b-NRXNs yield class I transmembrane proteins that share the
same C-terminal sequence and differ only in the extent of their
N-terminal extracellular region. After posttranslational cleavage
of an a-specific signal peptide, the extracellular region of the
mature a-NRXN contains nine independently folded domains,
including six laminin-neurexin-sex hormone-binding globulin
(LNS) domains separated by three epidermal growth factor
(EGF)-like domains, and a C-terminal O-glycosylated stalk
domain (100 amino acids) that forms an extended linker to
the transmembrane domain. The much smaller extracellular
region of b-NRXNs contains a b-specific signal peptide (cleaved
in the mature protein) and a short b-specific N-terminal
sequence followed by a single LNS domain, which is identical
to the LNS 6 domain of a-NRXN, and the same O-glycosylated
stalk domain (Figure 1A). NRXN mRNAs are subject to extensive
alternative splicing. There are five alternative splice sites in total,
SS#1 through 5. a-NRXNs are subject to splicing at all five splice
sites, and b-NRXNs only at SS#4 and #5. The diversity of NRXNs,
which is achieved by different genes, alternative promoters and
extensive splicing, results in the potential for thousands of iso-
forms (Tabuchi and Sudhof, 2002). Alternative splicing is thought
to function in the regulation of protein-protein interactions and is
potentially governing synapse specificity (Ullrich et al., 1995).
a- and b-neurexins function as cell-adhesion molecules
through their extracellular interaction with the postsynaptic neu-
roligins (NLGNs) (Ichtchenko et al., 1995, 1996). More recently
they have been found to also associate with the postsynaptic
leucine-rich repeat transmembrane proteins (LRRTMs) (de Wit
et al., 2009; Ko et al., 2009), the a4b2 nicotinic acetylcholine
receptor (Cheng et al., 2009), and the GABAA receptor (Zhang
et al., 2010). a-NRXN-1 was originally identified as a high-affinity
receptor for a spider neurotoxin, a-latrotoxin, which binds to
presynaptic receptors causing massive neurotransmitter
release (Davletov et al., 1995). Studies in mice identified the
extracellular region of a-NRXN-1 to be essential for the regula-
tion of Ca2+-dependent exocytosis in neurons (Missler et al.,
2003; Zhang et al., 2005). In addition to the postsynaptic partner
proteins described above, earlier studies showed that a-NRXNs
interact with a-dystroglycan through the LNS 2 and LNS
6/b-NRXN domains (Sugita et al., 2001) and to the soluble
neurexophilin proteins through the LNS 2 domain (Missler
et al., 1998). The precise roles of each of these interactions in
governing synaptic assemblies remain to be investigated., 767–778, June 8, 2011 ª2011 Elsevier Ltd All rights reserved 767
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Figure 1. The Structure of the a-NRXN-1
LNS 2-6 Extracellular Region
(A) Schematic representation of the mature a- and
b-NRXN class I transmembrane proteins. The
larger a-NRXNs differ from the shorter b-NRXNs in
the extent of their N-terminal extracellular region,
with a-NRXNs having six LNS domains inter-
spersed by three EGF domains and b-NRXNs
having only one LNS domain, identical to LNS 6 in
a-NRXN. The positions for alternative splicing
inserts are numbered and indicated with arrows.
(B) Ribbon representation of the crystal structure
of a-NRXN-1 LNS 2-6 in two orthogonal orienta-
tions. The predicted Ca2+-binding sites, displayed
as yellow spheres, were modeled from the Ca2+-
bound structures of LNS 2, 4, and 6. Approximate
dimensions of the asymmetric molecule are indi-
cated.
See also Figure S1.
Structure
Structure of a-Neurexin-1The NLGN molecules constitute another family of class I
transmembrane cell-adhesion proteins that are expressed post-
synaptically at either glutamatergic (NLGN-1, 3, 4) or
GABAergic (NLGN-2) synapses (Song et al., 1999; Varoqueaux
et al., 2004). Structurally, the interaction between the NLGN
and b-NRXNs has been extensively characterized. Two
b-NRXN molecules bind in a Ca2+-dependent manner on
opposing sides of the long axis of the dimeric NLGN molecule.
Crystal structures of the complexes between NLGN-1 or
NLGN-4 and b-NRXN-1 establish Ca2+-coordination at the
binding interfaces and support a regulatory mechanism at the
alternative splice site B of NLGN-1 (Arac et al., 2007; Chen
et al., 2008; Fabrichny et al., 2007; Leone et al., 2010).
Compared with b-NRXN, the extracellular region of a-NRXN is
structurally far more complex. It presents multiple independent
folding domains including two known functional protein-binding
domains, LNS 2 and LNS 6, which bind to multiple endogenous
partner proteins (described above). However, questions persist:
what is the synaptic disposition of the extracellular region of
a-NRXN in the limited space of the synaptic cleft, and how does
the association of the NRXNs with partners mediate synaptic
function through protein-protein interactions? We recently
demonstrated by single particle electron microscopy (EM) and
small angle X-ray scattering (SAXS) that the extracellular region
ofa-NRXN-1,comprisingLNS1 throughLNS6,adoptsasemilon-
gated shape with varying degrees of flexibility between the
independent LNS domains, of which the LNS 1 domain displayed768 Structure 19, 767–778, June 8, 2011 ª2011 Elsevier Ltd All rights reservedthe most pronounced flexibility (Comoletti
et al., 2010). In fact, removal of the LNS 1
and EGF 1 domains permitted the crystal-
lization of the remainder of the structured
extracellular domain.
Herein, we present the crystal struc-
ture, determined at 3.0 A˚ resolution,
of seven contiguous domains of the
a-NRXN-1 extracellular region, including
the LNS 2-6 domains and intervening
EGF 2 and 3 domains. The domains are
organized in an L-shaped conformationwith LNS 2-5 forming the longer arm, and EGF 3 and LNS 6
making up the short arm. The achievement of a high-resolution
picture of the domain arrangement and distinguishing binding
interfaces provides novel insights into the structural basis for
biological function. By a comparison with the structure of the
b-NRXN:NLGN complex, the a-NRXN structure is suitably
shaped to accommodate a NLGN molecule bound to LNS 6.
The structural analysis is supported by surface plasmon reso-
nance (SPR) studies in which we quantitatively compare the
binding affinities of b-NRXN-1 and various a-NRXN-1 trunca-
tions for NLGN-1. As previously seen from affinity pull-down
assays (Boucard et al., 2005), we demonstrate exclusive binding
of NLGN-1 to the LNS 6/b-NRXN domain. Furthermore, using
a series of a-NRXN constructs with incremental truncations of
each LNS domain, we show that the addition of LNS 2-5 domains
results in relatively small changes to the binding affinity for
NLGN-1. These data confirm the accessibility of the LNS 6
binding site in solution and support the argument for a high
affinity binding interaction between NLGN-1 and the full-length
a-NRXN molecule.
RESULTS
Three-Dimensional Structure of a-NRXN-1
The crystal structure of the glycosylated a-NRXN-1 extracel-
lular region, LNS 2 through LNS 6 (a-NRXN_2-6) containing
SS#3, was solved at 3.0 A˚ resolution by molecular replacement
Table 1. Data Collection and Refinement Statistics
X-ray Source SSRL BL11-1
Crystal Data
Space group C2
Cell dimensions
a, b, c (A˚) 199.7, 61.2, 155.6
a, b, g () 90.00, 121.21, 90.00
Data Collection
Processing software XDS package
Wavelength (A˚) 0.97945
Resolution (A˚) 30.0–3.02(3.13–3.02)
Rsym (%) 14.0 (62.8)
I / sI 8.7 (2.0)
Completeness (%) 97.9 (99.5)
No. of unique reflections 31,504 (3223)
Redundancy 3.4 (3.4)
Refinement
Resolution (A˚) 30.0–3.02 (3.10–3.02)
Rwork / Rfree (%) 21.4 (31.2)/26.9 (39.4)
No. atoms 7878
Protein 7795
Carbohydrate 50
Water 33
Average B overall (A˚2) 47.6
Rmsd bond length (A˚) 0.013
Rmsd bond angle () 1.369
Ramachandran plot
Preferred (%) 93.6
Allowed (%) 6.1
Outliers (%) 0.3
Values in parentheses are for the highest resolution shell.
Structure
Structure of a-Neurexin-1and refined (Table 1). It reveals a unique arrangement of
domains, which form an L-shape with the longer arm
composed of the LNS 2-5 and EGF 2 domains and the short
arm formed by the EGF 3 and LNS 6 domains (Figure 1B).
The LNS domains of the long arm are stacked in a similar orien-
tation such that the concave b sheet face of the N-terminal LNS
domain faces the convex b sheet face of the following
C-terminal LNS domain, making extensive interfacial contacts
through abundant hydrophobic and electrostatic interactions,
and organizing all of the predicted Ca2+-binding sites on the
same side of the molecule with similar inter-Ca2+ site distances
(26-42 A˚) (Figure 1B; see Figure S1A available online). Each of
the LNS domains, 2-5, has a Cys bond that anchors the
C-terminal loop to the convex b sheet face on the opposite
side of the predicted Ca2+-binding region. Furthermore, they
all anchor to the same b sheet (b12), with the exception of
LNS 4, which anchors to b13. This linker arrangement may
help maintain the overall architecture by directing the assembly
of each of the following C-terminal LNS domains. Accordingly,
the last LNS domain (LNS 6) is devoid of the Cys bond and
sequence homology indicates that the LNS 1 domain has the
same Cys connectivity.Structure 19The relatively small EGF-like domains (35 residues) maintain
a compact structural fold through a conserved cysteine sequence
pattern that results in the formation of three disulfide bonds. The
EGF 2 domain is located in proximal apposition with the LNS
3-LNS 4 interface, opposite the predicted Ca2+-binding sites of
both LNS domains. It further stabilizes the LNS 3-LNS 4 interface
by forming hydrogen bonds at either of its termini with the LNS 3
and 4 domains. At the junction between LNS 5 and EGF 3 there
are no strong stabilizing interdomain contacts, making an
apparent hinge point where the C-terminal EGF 3 and LNS 6
domains form a distinct arm of the protein. The EGF 3 domain
separates LNS 5 and LNS 6 by 35 A˚, displacing LNS 6 from
the linear arrangement of LNS 2-5 (Figure 1B). The extended
conformation of the EGF 3-LNS 6 arm is stabilized by abundant
interfacial contactswithanLNS5domainbelonging toasymmetry
related molecule (Figure S1B). The presence of a flexible hinge
between LNS 5 and EGF 3 suggests that the arm can assume
multiple conformations, as supported by a previous study using
independent techniques (Comoletti et al., 2010). The crystal struc-
ture likely represents one of these conformations.
There are two predicted N-linked glycosylation sites in the
sequence of a-NRXN_2-6, one on SS#3 in LNS 4 at N813 and
one at N1246 on LNS 6. The Fourier difference maps revealed
part of an N-linked glycan bound to N1246 on LNS 6, fitting the
electron density of two GlcNAc and one Mannose (Man) moie-
ties. Density is missing for most of SS#3 including the N813
glycosylation site. In addition to the N-linked glycosylation, the
Fourier difference maps revealed extra density extending away
from the hydroxyl group on S705 in EGF 2. This serine residue
belongs to a unique O-glycosylation consensus motif (C1-X- S/
T-X-P-C2) found between the first and second conserved cyste-
ines in EGF-like domains in several other extracellular proteins,
including the coagulation factor IX and the Notch cell surface
receptor signaling protein (Haines and Irvine, 2003; Harris and
Spellman, 1993). The complete form of the carbohydrate
structure found on these proteins is reported as Xyla1-3Xyla1-
3Glcb1-O-Ser (Okajima et al., 2008). Based on the conservation
of the consensus motif in the a-NRXN EGF 2 domain, we have
modeled a Glcb1 monosaccharide linked to S705, which is sup-
ported by the present density although the resolution limits
absolute identification of the sugar (Figure 2).
Comparison of LNS Domains
The independently solved NRXN-1 LNS domains 2, 4, and 6/
b-NRXN show high structural homology despite low sequence
identity (20%) (Koehnke et al., 2008, 2010; Rudenko et al.,
1999;Sheckler etal., 2006;Shenetal., 2008).Similarly, a compar-
ison of each of the individual domains with the corresponding
domain in the a-NRXN_2-6 molecule shows high structural simi-
larity (average rmsd of 0.5–0.9 A˚ for all atoms). The five LNS
domains in a-NRXN_2–6, which include the previously unsolved
LNS 3 and 5, all maintain the characteristic b sheet sandwich
containing 13 b strands making up the core of the domain
(Sheckler et al., 2006) (Figure 3). The face containing the pre-
dicted Ca2+-binding site, previously coined the ‘‘hypervariable’’
surface (Sheckler et al., 2006), also contains the sites for SS#2,
3, and 4 in LNS 2, 4, and 6, respectively, and a nonspliced insert
that creates a distinct flexible loop at the surface in LNS 3
between the b4 and b5 strands (‘‘LNS 3 loop’’) (Figure 3). In the, 767–778, June 8, 2011 ª2011 Elsevier Ltd All rights reserved 769
Figure 2. a-NRXN N- and O-Glycosylation
The a-NRXN_2-6 molecule with a b-Glc monosaccharide O-linked to S705 in
EGF 2 and a b-GlcNAcb1,4b-GlcNAcb1,4Man trisaccharide N-linked to N1246
in LNS 6 shown modeled into the density. Evidence for a b-Glc modification at
S705 comes from the conservation of an O-linked glycosylation motif found in
EGF-like domains of other extracellular proteins, including Notch and Factor
IX. TheN-linked glycosylation on N1246 matches the consensus glycosylation
site found in b-NRXN (PDB: 3mw2). The framed figures show the 2Fo-Fc map
(gray) for both sugars, contoured at 1.2 s around S705 and at 1.0 s around
N1246.
Figure 3. Comparison of the a-NRXN_2-6 LNS Domains
The five LNS domains in the a-NRXN_2-6 structure share a conserved
conformation with a characteristic 13 stranded b sheet fold. Regions of high
variation, measured by deviation in the Ca backbone, include the b11-b12 loop
(circled), a loop at the Ca2+-binding face in LNS 3 between b4 and b5 (small
black arrow), and the C-terminal segment including the a helix and proceeding
b sheet (boxed). Relative variation is depicted by color and size of the tube,
where thin blue tubes represent low variation and wide orange tubes show
greater variation. Residues that do not align with any other residues in
a sequence alignment of all five domains are colored in red.
See Figure S2.
Structure
Structure of a-Neurexin-1structure, the LNS 3 loop shows high flexibility (average B-factor
88 A˚2) and is oriented toward the LNS 4 domain with proximity to
the LNS 4Ca2+-binding site. Long-range electrostatic attractions
between the positively charged loop and negatively charged LNS
4surfaceare likely to influence theorientationof the flexible LNS3
loop (Figure S2A). The b11-b12 loop, which extends across the
concave side of the b sheet, diverges in structure for all of the
LNS domains. Compared with the LNS 6 domain, the b11-b12
loop is significantly larger in the LNS 2-5 domains, covering
a greater surface area of the concave side of the b sheet (Fig-
ure S2B). In LNS 2 and 3 the b11-b12 loop makes stabilizing
contacts between the adjacent LNS domains, LNS 3 and 4,
respectively. In LNS 4 the loop also makes extensive contacts,
predominantly with the symmetry-related LNS 5 domain that
participates in the organization of the EGF 3-LNS 6 arm. In LNS
5 the homologous loop is solvent accessible, as is the small
b11-b12 loop in LNS 6. Similar to the plant lectins, which have
a related fold and homologous b11-b12 loop involved in carbohy-
drate binding specificity, the variation in the b11-b12 loop in the
different LNS domains of a-NRXN is likely to confer selectivity
for the interacting surfaces (Rini, 1995; Sheckler et al., 2006).
The structure demonstrates that this variable surface loop in
each domain functions in distinctive ways in the assembly of
the full-length a-NRXN protein.Structural Comparison with the b-NRXN/NLGN Complex
a-NRXN-1 has two previously identified protein-binding
domains, LNS 2 and LNS 6, which bind to several endogenous770 Structure 19, 767–778, June 8, 2011 ª2011 Elsevier Ltd All rightspartner proteins (see Introduction). The previously described
NLGN binding site on LNS 6 is solvent accessible in the stabi-
lized conformation found in the a-NRXN_2-6 structure. To model
the complex between a-NRXN and NLGN-1, we superimposed
the structure of a-NRXN_2-6 onto the structures of the
b-NRXN-1 molecules bound to NLGN-1 (Arac et al., 2007). The
overlaid NLGN molecule interfaces with the a-NRXN_2-6 mole-
cule without significant steric obstruction, indicating that NLGN
could bind to a-NRXN_2-6 in the crystallized conformation
(Figure 4A). The LNS 6 domain of a-NRXN_2-6 shows high struc-
tural conservation at the binding interface to the NLGNmolecule,
as seen in the b-NRXN:NLGN complex structure. Despite thereserved
Figure 4. Overlay of a-NRXN_2-6 with
b-NRXN Bound to NLGN-1
(A) A model of a-NRXN_2-6 in complex with the
NLGN-1 dimer obtained by overlaying the LNS 6
domain in a-NRXN_2-6 onto the b-NRXN-1
molecules in the b-NRXN-1:NLGN-1 complex
(PDB: 3biw). The dimeric complex is shown as
a ribbon representation for the left half and
a surface representation for the right half. N and C
termini are indicated on the left half in black for
a-NRXN_2-6 and orange for NLGN-1. In the
model, a-NRXN_2-6 can accommodate the NLGN
molecule without steric hindrance, although with
close proximity to LNS 4 (see also Figure S3). The
NLGN-1 dimer is displayed in orange and
a-NRXN_2-6 is shown in gray (LNS 2-EGF 3) and
blue (LNS 6). On the right panel, a N-linked glycan
on LNS 6 (N1246) is shown in light blue.
(B) The NLGN binding interface of a-NRXN_2-6 is
conserved, as shown by the structural overlay with
the NGLN-1:b-NRXN structure. In particular, the
Ca2+-coordinating residues in b-NRXN (yellow)
retain their conformation in the a-NRXN_2-6 LNS 6
domain (blue) despite the absence of Ca2+.
Residue numbers are those of a-NRXN_2-6.
(C) An overlay of the Ca2+-free a-NRXN_2-6molecule with Ca2+-bound b-NRXN-1 (PDB: 3bod). The Ca2+ and water molecules in the b-NRXN structure are shown
as yellow and red spheres, respectively. The 2Fo-Fc maps contoured at 1.2 s are displayed in gray and the Fo-Fc maps contoured at 3.0 s in green. In the
absence of Ca2+, the LNS 6 domain in a-NRXN clearly coordinates an ion, which is likely to be sodium. Residue numbers are those of a-NRXN_2-6.
Structure
Structure of a-Neurexin-1absence of bound Ca2+, the predicted Ca2+-coordinating resi-
dues in LNS 6 maintain the same conformational arrangement
as observed in Ca2+-bound b-NRXNs either in complex with
NLGN or in their free form (Figures 4B and 4C). The Fourier
difference maps for a-NRXN_2-6 clearly show solvent density
in place of the Ca2+ in LNS 6 and not the other LNS domains
(Figure 4C). While LNS 6 presents the primary binding site for
NLGN (Boucard et al., 2005), the overlay shows the bound
NLGN to be adjacent to the LNS 4 domain of a-NRXN with no
significant steric obstruction between the a-NRXN and NLGN
molecules (Figure S3). In the overlay, the interfacing surface of
NLGN contains a flexible loop that includes the site for splice
insert A. The insert introduces an additional 20 residues and
would likely influence any interactions potentially mediated by
this surface (Figure S3). Similar results were produced in
a comparison with the structure of NLGN-4 bound to b-NRXN
(Fabrichny et al., 2007).
In the structure, the Ca2+ binding site on LNS 2, previously
shown to regulate binding to a-dystroglycan (Sugita et al.,
2001), is fully solvent accessible. However, absence of domains
LNS 1 and EGF 1 in the a-NRXN_2-6 structure precludes
a complete analysis of the exposed interfaces of LNS 2.
Binding Affinity Measurements of the a-NRXN:NLGN-1
Complex
a- and b-NRXNs share the same binding domain for NLGNs
(Boucard et al., 2005) and both demonstrate synaptogenic prop-
erties in cell culture (Graf et al., 2004, 2006; Kang et al., 2008).
Yet their evolutionary conservation suggests that they function
as independent molecules at the synapse. To address the
question of whether a- and b-NRXNs exhibit distinguishing
interactions with NLGN, we studied their individual binding prop-
erties by SPR. In these studies, the NLGN-1 dimer was immobi-Structure 19lized through a C-terminal Fc domain onto a Protein A-coupled
sensor chip and the monomeric NRXNs were injected as free
ligands.
Soluble constructs of b-NRXN-1 and subsets of the a-NRXN-1
molecule with sequential deletions of each LNS domain
(a-NRXN_2-6, a-NRXN_3-6, a-NRXN_4-6, a-NRXN_5-6) were
used to analyze binding affinities with NLGN-1 lacking splice
inserts A and B (NLGN-1-DAB) (Figure S4). b-NRXN-1 (DSS#4)
binds to NLGN-1DAB with 30 nM KD, comparable with previ-
ously published results (Arac et al., 2007; Comoletti et al.,
2006). The a-NRXN_5-6, a-NRXN_4-6 and a-NRXN_3-6
constructs all bind with a 2- to 3-fold lower affinity (higher KD)
and similar kinetics involving rapid bimolecular association and
unimolecular dissociation (Figure 5; Figure S5). The a-NRXN_2-
6 construct consistently yielded a KD of 10–30 nM, reversing
the trend of a slight decrease in KD with the additional domains.
When normalized against themaximum binding response (Rmax),
compared with the other truncated a-NRXNs, a-NRXN_2-6
shows the same fast bimolecular association, but displays
a different dissociation profile consisting of an initial fast dissoci-
ation phase of greater amplitude, followed by a slow secondary
dissociation (Figure S5). Tight clustering in the calculated KD
values across multiple surfaces with various densities of immo-
bilized NLGN-1 attests to reproducibility of the measurements
(Figure 5). Additionally, as was previously demonstrated by
pull-down studies (Boucard et al., 2005), no binding to NLGN-1
was observed using the a-NRXN_2-5 construct at concentra-
tions approaching 3 mM (Figure S5). Although the specific recog-
nition properties of the individual LNS domains remain to be
resolved, the comparative equilibrium dissociation constants
between the b-NRXN and truncated a-NRXNs demonstrate
that both molecules can bind with low nM KD’s (high affinity).
The 2- to 3-fold increase in KD (decrease in affinity) for a-NRXN, 767–778, June 8, 2011 ª2011 Elsevier Ltd All rights reserved 771
Figure 5. NRXN-NLGN Association at EquilibriumMeasured by SPR
Four truncated a-NRXN constructs and b-NRXN were injected over immobi-
lized NLGN-1. Equilibrium dissociation constants were independently calcu-
lated from four surfaces with variable densities of NLGN-1 (the four curves are
shown for each construct). The mean KD values for each construct are shown
in the lower right graph (error bars indicate standard deviation). All five
constructs bind to NLGN-1 with low nM affinity, indicating similar accessibility
of the NLGN binding site on LNS 6 of the different truncated a-NRXN mole-
cules. See also Figure S5.
Structure
Structure of a-Neurexin-1corresponds to only minimal differences in free energy require-
ments for binding and therefore supports the model of a flexible
hinge between LNS 5 and EGF 3 in a-NRXN-1.
DISCUSSION
The structural characterization of the a-NRXN-1 extracellular
region reveals how the concatenated five LNS and two EGF
domains assemble into a L-shaped molecule and provides
insights into its function as a receptor for several endogenous
partnering proteins in the limited dimensions of a synaptic cleft.
A complementary SPR analysis shows that a-NRXN binding to
NLGN-1 ismostly triggered by the LNS 6/b-NRXNdomain, which
is likely to be accessible in solution due to a flexible linker
between LNS 5 and EGF 3. The high-resolution structure reveals
the accessibility to known protein interaction sites, provides
details on the atomic interactions leading to the assembled
domains, and offers more insight on the flexible properties of772 Structure 19, 767–778, June 8, 2011 ª2011 Elsevier Ltd All rightsthe protein compared with the previously determined EM and
SAXS structures (Comoletti et al., 2010).
Overlaying the a-NRXN_2-6 structure on the 2D EM images of
a-NRXN_1-6 demonstrates a similar overall arrangement of the
domains despite the distinctive methodologies, and shows
possible orientations of the flexible LNS 1 domain in relation to
the other domains (Figure 6). Evident in the crystal structure,
the extent of interdomain contacts between LNS 2-5 suggests
limited flexibility in their linear arrangement. On the other
hand, a lack of strong stabilizing interactions at the connection
between LNS 5 and EGF 3 (P1106) is indicative of innate
flexibility at this position in the molecule, suggesting that the
extension of the EGF 3-LNS 6 domains observed in our structure
is one of the possible conformations affording solvent accessi-
bility. The previously reported EM/SAXS models were specifi-
cally discussed in terms of ‘‘ensembles of structures’’ (Comoletti
et al., 2010), supporting the notion that the LNS 6 domain can
fold in toward the LNS 4 domain, creating either a more compact
Y-shaped conformation or an extended L-shaped conformation
as observed in the crystal structure. In agreement with the SPR
studies, the dynamic arrangement of the two arms is likely to
influence the binding kinetics with partner proteins such as
NLGN, with the extended conformation granting an energetically
favorable state for association.
Predicted Ca2+-Binding Sites in the a-NRXN-1
Extracellular Region
a-NRXN-1 interacts with the postsynaptic NLGNs, LLRTM and
a-dystroglycan proteins in a Ca2+-dependent manner through
the LNS 2 and/or LNS 6 domains (Arac et al., 2007; Ko
et al., 2009; Sugita et al., 2001). In the structure, all of the pre-
dicted Ca2+-binding sites are aligned on the outer surface of
the molecule with similar intersite distances. The coordinating
atoms at the Ca2+-binding sites in LNS domains 2, 3, and 6
have a conserved spatial arrangement based on a structural
overlay with the Ca2+-bound structures of the LNS 2, 4, and
6/b-NRXN domains (Rudenko et al., 1999; Sheckler et al.,
2006; Shen et al., 2008). For the LNS 6 domain, the Fourier
difference maps show solvent coordination at the previously
reported Ca2+-binding site (Koehnke et al., 2008; Shen et al.,
2008), and may indicate a higher affinity site for divalent cation
coordination compared with the other domains. On the other
hand, based on a structural overlay, the inclusion of an insert
at SS#3 in LNS 4 near the Ca2+-binding site, may reduce the
Ca2+ affinity by altering the conformation of the coordinating
L805 carbonyl oxygen (Shen et al., 2008). The loss of measur-
able Ca2+-binding to the LNS 2 domain due to an insert at
SS#2 was previously demonstrated by isothermal titration
calorimetry (Sheckler et al., 2006). The predicted Ca2+-binding
site in LNS 5 appears intact, however, unlike the LNS 2, 3,
and 6 domains that show conserved spatial distances
between the coordinating atoms, the LNS 5 domain has a
more open site with increased interatomic distances. A defini-
tive analysis of Ca2+-binding of a-NRXN awaits a structure with
bound Ca2+.
Splice Sites in the a-NRXN_2-6 Structure
a-NRXN-1 has five sites of alternative splicing, three of which are
found within the a-NRXN_2-6 sequence, SS#2 on LNS 2, SS#3reserved
Figure 6. 2D Overlay of the a-NRXN_2-6
Structure on Negative Stain EM Images
A 2D image of the a-NRXN_2-6 structure overlaid
onto three previously published 2D negative stain
single particle EM images of the a-NRXN_1-6
purified protein (Comoletti et al., 2010). The overall
arrangement of the LNS 2-6 domains is conserved
and the variable placement of the flexible LNS 1
domain relative to the crystal structure is
observed.
Structure
Structure of a-Neurexin-1on LNS 4 and SS#4 on LNS 6. We have crystallized a-NRXN_2-6
containing the 10 amino acid insert at SS#3 (sequence
DCIRINCNSS). The structure lacks density for six of the ten resi-
dues (R809-S815), probably due to the flexible nature of the
segment, but the insert appears to create an extended loop
between the b6-b7 sheets that does not significantly alter the
conformation of the LNS 4 domain compared with the
structure of LNS 4 devoid of SS#3 (Shen et al., 2008). Predicted
structural features of the splice insert include a disulfide bond
between C807 and C812 and an N-linked glycosylation site at
N813. The splice insert lies proximal to the LNS 4 Ca2+-binding
site and, together with the LNS 3 loop (K546-V561) that also
extends toward the LNS 4 Ca2+-binding site, seems to
partially occlude access of potential protein ligands to the
Ca2+-binding face.
Our structure does not contain an insert at SS#2 on LNS 2 or
SS#4 on LNS 6. A structural comparison between the LNS 6
domain and two structures of b-NRXN-1 containing the splice
insert (SS#4) (Koehnke et al., 2010; Shen et al., 2008) shows
that, while the two b-NRXN structures propose different confor-
mations of the splice insert, either conformation could exist in the
a-NRXN structure presented here.
O-Glycosylation of EGF 2 in a-NRXN-1
The a-NRXN_2-6 structure reveals a previously uncharacterized
O-linked glycosylation site on the first Ser residue in the EGF 2
domain. The identification of a single O-b-glucose moiety was
based on the sequence alignment with a conserved O-glycosyl-
ation consensus motif previously identified in EGF-like domains
in other cell-surface and secreted proteins, including factor VII,
factor IX, protein Z and Notch (Haines and Irvine, 2003; Harris
and Spellman, 1993). Two unusual O-linked glycans have been
mapped to consensus sequences in EGF-like domains, yielding
either an O-glucose or O-fucose posttranslational modification
(Harris and Spellman, 1993). The Notch receptor is made up of
a series of EGF-like repeats in which the O-fucosylation pattern
functions to modulate protein interactions that determine
signal transduction capabilities (Haines and Irvine, 2003; Oka-
jima et al., 2008). Many of the EGF-like domains in Notch contain
theO-glucosemodification, but a specific biological role remains
to be determined (Moloney et al., 2000). In a-NRXN_2-6 the EGF
2 domain contains the consensus sequence for the O-glucose
modification site. Accordingly, the structure shows a singleStructure 19, 767–778, June 8, 2011glucose moiety attached to the EGF 2
domain. Although the preservation of
such a moiety in a-NRXN-1 expressed
in neurons remains to be determined,we illustrate here the possibility for a new glycosylation pattern
of a-NRXN-1 that is likely to influence its function.
Disease-Linked Mutations in the a-NRXN-1
Extracellular Region
An increasing number of genetic studies implicate the NRXN-1
gene and its partnering NLGN genes as important determinants
for the pathogenesis of several diseases of the central nervous
system, including ASD, schizophrenia, Pitt-Hopkins-like
syndrome-2, and milder forms of mental retardation (Kim et al.,
2008; Rujescu et al., 2009; Sebat et al., 2007; Yan et al., 2008;
Zahir et al., 2008; Zweier et al., 2009). Identified genetic abnor-
malities include copy number variations (Glessner et al., 2009;
Rujescu et al., 2009; Sebat et al., 2007; Szatmari et al., 2007),
chromosomal alterations (Kim et al., 2008; Yan et al., 2008; Zahir
et al., 2008) and a few rare sequence mutations (Feng et al.,
2006; Kim et al., 2008; Yan et al., 2008; Zweier et al., 2009).
Reported missense mutations in the NRXN-1 gene include four
sites in the a-NRXN-1 leader sequence (Kim et al., 2008;
Yan et al., 2008), two in the b-NRXN-1 leader sequence
(Feng et al., 2006), one in the EGF 2 domain (Kim et al., 2008;
Yan et al., 2008), two flanking the EGF 2 domain, in LNS 3
and 4 (Yan et al., 2008) and one in the LNS 5 domain that leads
to a premature stop codon (Zweier et al., 2009). The ASD-
associated mutations found on the mature protein are clustered
around the EGF 2 domain. They include T688I, L731I, and E738K
(Figure S6). Mapping these disease-associated mutations does
not reveal a defining role that should be disrupted by the muta-
tions; however, their proximity may point to an important region
of the protein for processing and/or functional regulation.
A number of rare structural variants have also been identified
in the partnering NLGN proteins (Comoletti et al., 2004; Talebiza-
deh et al., 2006; Yan et al., 2005). One reported NLGN mutation
(NLGN-4 G99S) is exposed to a solvent surface of the NLGN
dimer and shows proximity to the overlaid a-NRXN molecule
such that the mutation may affect the surface or alter its confor-
mation to influence a-NRXN binding (Figure S6).
The a-NRXN:NLGN Complex
a- and b-NRXNs share the same binding domain for the NLGNs;
however, it is not fully understood if these comparable interac-
tions are functionally distinct. Binding properties between the
NLGNs and b-NRXNs in their various splice isoforms haveª2011 Elsevier Ltd All rights reserved 773
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Structure of a-Neurexin-1been extensively studied using SPR (Arac et al., 2007; Boucard
et al., 2005; Comoletti et al., 2003, 2006; Koehnke et al., 2010).
Information on the a-NRXN binding properties with NLGN has
been limited to data from affinity pull-down assays and a single
SPR experiment comparing the relative affinities of a-NRXN-1
with NLGN-1 (Reissner et al., 2008). Pull-down experiments
concluded that a-NRXN-1, with or without splice insert #4,
binds to NLGN-1-3 and is regulated by splice insert B in
NLGN-1 and that binding is exclusively mediated by the LNS
6 domain (Boucard et al., 2005). Another pull-down experiment
suggested that a-NRXN-1 binding to NLGN-1 containing splice
insert B is regulated by the structural constraints imposed by
the disulfide bonds in the EGF 3 domain (Reissner et al.,
2008). By SPR, the relative binding affinity of a-NRXN-1
compared with b-NRXN-1 with NLGN-1 was reported to be
2-fold less when a-NRXN lacks SS#4 and 4-fold less with
SS#4 (Boucard et al., 2005).
We suggest that the flexibility of the EGF 3-LNS 6 arm has
functional implications on the accessibility of the LNS 6 binding
site to receptor proteins, including the NLGNs. By superimpos-
ing the a-NRXN_2-6 structure on the b-NRXN:NLGN complexes,
it becomes apparent that the EGF 3-LNS 6 arm must be in an
extended conformation in order to accommodate the NLGN
molecule without steric hindrance. Our SPR data show that the
sequential addition of LNS domains 2–5 to LNS 6 results in, at
most, a 2- to 3-fold decrease in affinity for NLGN-1 compared
with b-NRXN. These variations in the KD values indicate minimal
differences in free energy requirements for binding of the
truncated NRXNs. Hence, modest conformational adjustments
are needed for a-NRXN to accommodate the NLGN molecule,
thereby supporting the propensity for a-NRXN to form an
extended conformation as revealed in the crystal structure.
In the superimposed crystal structure, the LNS 4, 5, and 6
domains fit snugly around the NLGN molecule without evident
hindrance, yet with an apparent interface between LNS 4 and
NLGN (Figure S3). The position of splice insert A in NLGN-1
and 2 at the proximal interface with LNS 4 prompts the ques-
tion of whether there is a functional role for splice site A in
NLGN binding affinities for the a-NRXNs. A previous study
showed that the presence of splice insert A in NLGN-1, in the
absence of splice insert B, or in NLGN-2 promotes targeting of
either NLGN to GABAergic synapses (Chih et al., 2006). The
insert at splice site A adds 20 amino acid residues to the struc-
ture and is heavily populated with both cationic and anionic resi-
dues. The proximity of this loop region in the structural overlay
suggests that the combination of bulk and charge of the added
sequence would impact NLGN binding to the a-NRXN_2-6 in
the conformation shown here. Overall, it remains to be deter-
mined if the a-NRXN:NLGN complex stabilizes the L-shape
configuration of the domains, or if the two arms would preferen-
tially open up to form an obtuse configuration and if there is a role
for splicing in establishing selectivity of interaction. In either case
the EGF 3 domain separates the LNS 6 domain from the other
five LNS domains in order to accommodate the NLGNmolecule.
A Working Model of the a-NRXN:NLGN Complex
at the Synapse
Both the a-NRXN and NLGN molecules have long, semiflexible
stalk domains connecting their extracellular binding domains774 Structure 19, 767–778, June 8, 2011 ª2011 Elsevier Ltd All rightsto the cell membrane. The stalk regions contain a relatively large
number of serine and threonine residues that areO-glycosylated
(Ushkaryov et al., 1992). The glycosylation pattern confers some
hydration to the chain and the combination of oligosaccharides
and proline amino acid residues is thought to impart some
rigidity to the peptide chain, as demonstrated in NLGN-1 and
other cell surface receptors (Comoletti et al., 2007; Merry et al.,
2003).
The crystal structure of a-NRXN_2-6 has a maximum length of
130 A˚. The full extracellular region of a-NRXN has an additional
N-terminal LNS domain (LNS 1) and EGF domain (EGF 1), which
elongates the soluble protein by35 A˚, but also shows extensive
flexibility (Comoletti et al., 2010). Therefore, depending on the
orientations of the LNS 1 domain and the stalk domain, the
maximum dimension of the full extracellular region of a-NRXN
approaches or possibly exceeds the membrane-to-membrane
distance of a typical synaptic cleft (200 A˚). However, in a similar
case, structural studies on the large cell-adhesion proteins,
cadherins, indicate that they may create repulsive forces
that increase the distance between pre- and postsynaptic
membranes to approximately 250 A˚ (Craig et al., 2006).
Crystal structures of the complexes between the extracellular
domains of NLGN and b-NRXN show a NLGN dimer is formed
through a hydrophobic four helix bundle involving the C-terminal
a helices in each subunit with the two C termini pointing in one
direction and two b-NRXN molecules bound on opposite sides
of the long axis of the NLGN dimer with their C termini pointing
opposite to the NLGN C termini (Arac et al., 2007; Chen et al.,
2008; Fabrichny et al., 2007). The opposing directionality of the
C termini of b-NRXN and NLGN is indicative of their tethering to
the pre- and postsynaptic membranes, respectively. Overlaying
a-NRXN onto the b-NRXN:NLGN complex positions the LNS 2-5
armofa-NRXNperpendicular to themembrane (Figure 7). If stabi-
lized in this conformation, the N-terminal domains of a-NRXN
would lie in close proximity to the presynaptic membrane.
a-NRXNs are distinct from b-NRXNs in their capacity to regu-
late Ca2+-dependent exocytosis at the presynapse, a role that is
believed to be a function of the a-specific domains (Missler et al.,
2003; Zhang et al., 2005). Furthermore, a-NRXNs are receptors
for the a-latrotoxin protein and function by recruiting the toxin
to the presynaptic membrane where it can position itself to stim-
ulate exocytosis (Sudhof, 2001). Therefore, a spatial arrange-
ment of a-NRXN with its N terminus close to the presynaptic
membrane could favor the observed regulation of Ca2+-depen-
dent neurotransmitter release.
On the other hand, the N-terminal domains of a-NRXN may
also function by interacting with proteins on the postsynaptic
membrane, as evident from LNS 2 binding to a-dystroglycan
(Sugita et al., 2001). The extent of torsional flexibility in the region
between LNS 5 and EGF 3, as dictated by the a-NRXN:NLGN
complex, may allow for the long arm of a-NRXN to open into
a more linear arrangement, lateral to the membrane, thereby
allowing the a-NRXN to form additional contacts with postsyn-
aptic receptor proteins (Figure 7). The two identified protein-
binding domains, LNS 2 and LNS 6, are separated by 100 A˚,
which indicates that with the appropriate alignment, both sites
could be occupied at the same time. The potential of a-NRXNs
to host multiple partnering proteins suggests a possible scaf-
fold-like functionality that would determine the architecturalreserved
Figure 7. Model of the a-NRXN:NLGN Complex at the Synapse
Overlays of a-NRXN_2-6 onto b-NRXN-1 as bound to NLGN-1 or -4 suggests
a possible position for the a-NRXN:NLGN complex in the synaptic cleft. The
overlaid complex is shown with the C termini of a-NRXN and NLGN oriented
toward the pre- and postsynaptic membranes, respectively. In this confor-
mation the N-terminal domains lie proximal to the presynaptic membrane
(conformation A, nontransparent surface,). Flexibility at the hinge point
between LNS 5 and EGF 3 could allow segmental motion of the a-NRXN_2-6
long arm toward a fully linear conformation of the extracellular region, moving
the N-terminal domains in closer proximity to the postsynaptic membrane
(conformation B, transparent surface). The relative position of the N-terminal
domains is likely to confer selectivity for additional binding partners. The NLGN
dimer is colored in orange, the a-NRXN LNS 2-EGF 3 in gray and LNS 6 in blue.
Stalk domains for NLGN and a-NRXN_2-6, shown in semitransparent orange
and blue, respectively, were modeled into the figure.
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Structure of a-Neurexin-1spacing of the molecular network in the trans-synaptic space.
Therefore, future studies to address the possible conformations
of the a-NRXN domains when bound to NLGN will be of interest.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Protein Purification
The original bovine cDNA encoding the secreted, soluble extracellular region
of a-NRXN-1 fused with a C-terminal IgG Fc domain to permit affinity chroma-
tography, and inserted in expression vector p-cDNA 3.1, was a gift from
Dr. Thomas Sudhof (Ushkaryov et al., 1992). The construct was further modi-
fied to introduce a 3Cpro cleavage site upstream from the Fc domain as
described previously (Comoletti et al., 2010). All modified a-NRXN constructs
contained the original expression vector, signal peptide sequence and Fc
sequence. a-NRXN-1 and its various truncated forms were expressed in the
mammalian cell line, HEK293 GnT1-, lacking the N-acetyglucosaminyltrans-
ferase I gene needed for high-order N-linked glycosylation processing. The
soluble recombinant b-NRXN-1 protein used for SPR studies was expressed
in bacterial Rosetta Plys cells as an N-terminally 6-His tagged protein as previ-
ously described (Fabrichny et al., 2007).
NLGN1DAB (residues Q46-S693 without splice inserts A or B) was cloned
into p-cDNA 3.1 between the sequences encoding the a-NRXN signal peptide
and the C-terminal 3Cpro cleavage site, itself followed by the sequence en-
coding the Fc domain. This construct was transfected into HEK293 cells for
expression in selected stable cell lines.
Crystallization and X-ray Data Collection
a-NRXN-1 containing domains LNS 2 through LNS 6 (a-NRXN_2-6), residues
296–1349 (NP_776829), lacking inserts at SS#2 and #4 but containing the ten-
residue splice insert at SS #3 (Figure S4) was concentrated to 3 mg/ml in
HEPES buffered saline (pH 7.4) (HBS). Crystals grew as thin rods by sitting
drop vapor diffusion at 14C in 96-well plates (Innovaplate SD-2, Innovadyne
Technologies). Drops of 0.6 ml were set at a 1:1 (v/v) ratio of protein to reservoir
buffer (0.1 M Bicine pH 9.0, 12% PEG 20,000, 1 mM EDTA). Crystals were
soaked into the mother liquor complemented with 10%–25% glycerol forStructure 19several minutes before being flash cooled in liquid nitrogen. X-ray diffraction
data were collected at a temperature of 100 K from the 11-1 beamline at the
Stanford Synchrotron Radiation Lightsource (SSRL, Menlo Park, CA). Diffrac-
tion data were processed with the XDS package (Kabsch, 1993).
The crystals belong to space group C2 and contain one a-NRXN_2-6 mole-
cule per asymmetric unit with a solvent content of 65%.
Extensive attempts to crystallize the protein in the presence of Ca2+ were
unsuccessful. Crystals were grown under the Ca2+-free conditions reported
here, both with and without the additive EDTA. Soaking the crystals grown
without EDTA in a cryo buffer containing 1–10 mM Ca2+ did not yield high-
quality diffraction patterns. The majority of the crystals had a very thin third
dimension andwere either too fragile to harvest or producedweak, anisotropic
diffraction in the 4–8 A˚ range.
Structure Determination, Refinement, and Validation
The structure of a-NRXN_2-6 was determined at 3.0 A˚ resolution by molecular
replacement using the coordinates of previously solved structures for LNS 2
(PDB 2h0b), LNS 4 (PDB 2r16), and b-NRXN (PDB 3bod) as search models
for input into PHASER (McCoy et al., 2007). An initial search using the three
PDB structures successfully located the LNS 2, 4, and 6 domains. Using the
phase information from the previous search, the LNS 3 and 5 domains were
located using the coordinates of the LNS 2 and LNS 4 structures, respectively.
Building of LNS 3 and 5 was achieved through subsequent cycles of modeling
and refinement. After rigid body refinement of all LNS domains, the EGF-like
domains were manually built into the difference Fourier maps using Coot. In
the final refinement stages, each LNS and EGF domain was used to define
seven TLS groups for refinement. All model building and refinement was per-
formed in Coot (Emsley and Cowtan, 2004) and Refmac5 from the CCP4
program suite (CCP4, 1994). A combination of Whatcheck (Hooft et al.,
1996) and Molprobity (Chen et al., 2010) were used for structure validation.
The structure was refined to a final Rwork = 0.21 and Rfree = 0.27 and shows
1005 amino acid residues. It shows no density for residues K551-D552 in
LNS 3 and R809-S815 in LNS 4. The latter sequence corresponds to most
of SS#3. The structure also includes 33 water molecules, one b-Glc moiety
O-linked to S705 in the EGF 2 domain, and part of an N-linked glycan bound
to N1246 in LNS 6, fitting the electron density of two molecules of GlcNAc
and one Man.
Structural Analysis
All analyses of the domains interfaces used the PDBePISA server (http://www.
ebi.ac.uk/msd-srv/prot_int/pistart.html) (Krissinel and Henrick, 2007). Average
rmsds of individual LNS domains were calculated using the secondary struc-
ture matching module in COOT (Emsley and Cowtan, 2004). Overlays of the
previously solved LNS 2, 4, and 6/b-NRXN domains (PDB: 2h0b, 2r16, and
3bod) onto their respective domains in the a-NRXN_2-6 structure gave
average rmsd values between 0.5 and 0.9 A˚ between Ca atoms. Comparing
the five individual LNS domains in the a-NRXN_2-6 structure yielded average
rmsds of 1.42–2.3 A˚ for Ca atoms. Individual Ca rmsds between the LNS
domain in a-NRXN_2-6 were calculated using ClustalW (Chenna et al., 2003)
and the THESEUS software package (Theobald and Wuttke, 2006). Structural
overlays of a-NRXN_2-6 with the b-NRXN:NLGN-1 or b-NRXN:NLGN-4
complexes (PDB: 3biw and 2xb6, respectively), a-NRXN_2-6 with the
b-NRXN+SS#4 structures (PDB: 2r1b and 3mw2) and the NLGN-2 dimer
(PDB: 3bl8) with the b-NRXN:NLGN-1 complex were performed using the
secondary-structure matching (SSM) module in Coot. All structure figures
and electrostatics calculations were generated using PyMol (DeLano Scien-
tific, LLC).
Surface Plasmon Resonance
For details of the NRXN proteins used for the SPR studies, see Figure S4. All
NRXN proteins were analyzed for binding against the NLGN-1DAB isoform.
Affinity binding analysis was performed on a ProteON X36 biosensor with
the GLC chip platform (Bio-Rad Laboratories, Inc.) in a running buffer made
of HBS, 3 mM Ca2+, 0.05% Tween 20, 1 mg/ml bovine serum albumin, at
25C. For more details, see the Supplemental Information.
The GLC chip was equilibrated in HBS buffer at 25C for immobilization of
NLGN to the monolayered surface of the sensor chip. Protein A was immobi-
lized on the biosensor chip surface in the vertical direction using amine, 767–778, June 8, 2011 ª2011 Elsevier Ltd All rights reserved 775
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Structure of a-Neurexin-1coupling chemistry (Rich and Myszka, 2001). The surfaces were deactivated
with 1 M ethanolamine and washed with glycine (pH 2.0). NLGN-1DAB-Fc
was captured over the Protein A surface from filtered medium of cultured
HEK293 cells (injected in vertical orientation at 30 ml/min). One channel was
dedicated as a control where medium from nontransfected HEK293 cells
was injected. Different dilutions of the medium were used to achieve variable
amounts of NLGN-1 on the surface, which was necessary to achieve an
optimal signal level (RUs) for the various NRXN analytes, which ranged from
22 kDa for b-NRXN to 140 kDa for a-NRXN_1-6.
Affinity binding analysis was performed in a running buffer made of HBS,
3 mM Ca2+, 0.05% Tween 20, 1 mg/ml BSA at 25C. In the experiment shown
here, each NRXN protein was prepared in a 2-fold dilution sequence in
running buffer starting at a concentration of 15.6 nM and ending at 1 mM.
Additional experiments were performed using a 3-fold concentration gradient
going from 1.2 to 900 nM. For each injection series, one channel was injected
with running buffer to use as a double reference (Myszka, 1999). Samples
were injected orthogonal to the NLGN surfaces for 60 sec, at a flow rate of
50 ml/min, followed by a 600 sec dissociation phase. For each injection, the
NRXN analyte was exposed to five independent surfaces with NLGN-1DAB
and one surface with only Protein A. The surface was regenerated with an
18 sec injection of 350 mM EDTA, at 100 ml/min after each injection, followed
by a 60 sec injection of running buffer at 100 ml/min. The lack of binding on
control Protein A surfaces upon injection of culture medium from nontrans-
fected HEK293 cells or containing a-NRXN_1-6 with a C-terminal Fc fragment
verified the absence of appreciable nonspecific binding. The graphs shown
here were generated using GraphPad Prism v.4.0b (Graphpad Software, La
Jolla, CA).
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In this issue, Chen et al. report crystal structures of a-NRXN-1, LNS 2-6, with
and without SS#3. Remarkable similarities in structural features and proposed
biological implications are reported in both ours and Chen et al.’s study,
including a potential role for NLGN splice site A in determining a splice-depen-778 Structure 19, 767–778, June 8, 2011 ª2011 Elsevier Ltd All rightsdent protein recognition pattern for a-NRXN, and a suggested role for a-NRXN
in mediating the assembly of multiple pre- and postsynaptic proteins in the
synaptic cleft.
Interestingly, crystallization in the presence of either 2.5 mM CaCl2 (Chen
et al.) or 1mM EDTA (Miller et al.) yields similar structures and crystal packing.
Additionally, we find a putative O-glycosylation site in the EGF 2 domain and
characterize, by SPR binding measurements, accessibility of NLGN-1 to its
primary site on a-NRXN-1, LNS 6.
Finally, new evidence supporting our hypothesis of a variable LNS 5-EGF 3
interface is provided by a recently released structure of the LNS 5-EGF 3-LNS
6 domains of a-NRXN-1 by Tenaka et al. (PDB: 3ASI), in which the LNS 5-EGF 3
interface displays some differences, but the more extensive EGF 3-LNS 6
interface parallels our structure. Together, these studies highlight the major
structural features likely to influence a-NRXN-1 function at the synapse.reserved
